Immuneering Corp logo

Immuneering Corp

$ 4.45 +0.04 (+0.91%) 10:08 PM EST
P/E:
At Loss
P/B:
0.96
Market Cap:
$ 117.50M
Enterprise V:
$ 5.16M
Volume:
33.48K
Avg Vol (2M):
41.68K
Volume:
33.48K
Market Cap $:
117.50M
PE Ratio:
At Loss
Avg Vol (2-Month):
41.68K
Enterprise Value $:
5.16M
PB Ratio:
0.96

Business Description

Description
Immuneering Corp is a biopharmaceutical company. It is focused on improving patient outcomes across a spectrum of debilitating oncologic and neurologic diseases by applying deep knowledge of translational bioinformatics to every stage of the drug development process. The company's proprietary computational Disease Cancelling Technology platform enables Immuneering's drug discovery programs. The company also provides unparalleled computational biology capabilities to leading pharmaceutical and biotechnology companies.
Name Current Vs Industry Vs History
Cash-To-Debt 24.15
Equity-to-Asset 0.91
Debt-to-Equity 0.04
Debt-to-EBITDA -0.1
Interest Coverage N/A
N/A
N/A
Piotroski F-Score N/A/9
0
1
2
3
4
5
6
7
8
9
Altman Z-Score 4.79
Distress
Grey
Safe
Beneish M-Score -5.62
Manipulator
Not Manipulator
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History

Momentum Rank

Name Current Vs Industry Vs History
5-Day RSI 55.65
9-Day RSI 51.41
14-Day RSI 46.32
6-1 Month Momentum % -32.74
12-1 Month Momentum % -60.7

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 16.54
Quick Ratio 16.54
Cash Ratio 16.15
Days Sales Outstanding 179.61
Days Payable 1686.42

Dividend & Buy Back

Name Current Vs Industry Vs History